Equitable Trust CO Illumina, Inc. Transaction History

Equitable Trust CO

$1.47 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$128.91 - $192.44 $11,086 - $16,549	-86 Reduced 5.12%	1,593 $218,000
Q2 2023 Aug 09, 2023	SELL	$183.43 - $232.67 $69,886 - $88,647	-381 Reduced 18.5%	1,679 $314,000
Q1 2023 May 08, 2023	SELL	$193.75 - $232.55 $320,462 - $384,637	-1,654 Reduced 44.53%	2,060 $479,000
Q4 2022 Feb 21, 2023	SELL	$187.24 - $242.74 $765,062 - $991,835	-4,086 Reduced 52.38%	3,714 $750,000
Q3 2022 Nov 03, 2022	SELL	$177.23 - $227.44 $135,049 - $173,309	-762 Reduced 8.9%	7,800 $1.49 Million
Q2 2022 Jul 15, 2022	SELL	$181.58 - $368.0 $318,309 - $645,104	-1,753 Reduced 16.99%	8,562 $1.58 Million
Q1 2022 May 06, 2022	SELL	$303.87 - $423.8 $473,429 - $660,280	-1,558 Reduced 13.12%	10,315 $3.6 Million
Q4 2021 Jan 31, 2022	SELL	$347.28 - $421.83 $2.24 Million - $2.72 Million	-6,449 Reduced 35.2%	11,873 $4.52 Million
Q3 2021 Oct 26, 2021	SELL	$405.61 - $524.84 $267,702 - $346,394	-660 Reduced 3.48%	18,322 $7.43 Million
Q2 2021 Aug 03, 2021	SELL	$372.84 - $481.5 $757,238 - $977,926	-2,031 Reduced 9.67%	18,982 $8.98 Million
Q1 2021 May 14, 2021	BUY	$361.28 - $504.76 $215,684 - $301,341	597 Added 2.92%	21,013 $8.07 Million
Q4 2020 Feb 12, 2021	BUY	$292.7 - $370.96 $3.29 Million - $4.17 Million	11,235 Added 122.37%	20,416 $7.55 Million
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $90,219 - $134,648	336 Added 3.8%	9,181 $2.84 Million
Q2 2020 Aug 18, 2020	SELL	$256.46 - $373.01 $69,500 - $101,085	-271 Reduced 2.97%	8,845 $3.28 Million
Q1 2020 May 21, 2020	BUY	$209.2 - $335.53 $1.91 Million - $3.06 Million	9,116 New	9,116 $2.49 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account